On the basis of a number of studies, active surveillance has emerged as a viable option for managing selected men with low-risk prostate cancer.
Relatively short life expectancy, as suggested by patient age and comorbid illnesses, are one of the considerations when deciding whether active surveillance is appropriate. Other considerations include desire to avoid erectile dysfunction (ED) and urinary incontinence.
The right age at which active surveillance should considered is unclear, but younger men (e.g., less than 60 years old) in relatively good health can expect to live longer with their prostate cancer, increasing their risk of dying from it.
Renal & Urology News would like to know how urologists would deal with this clinical scenario, so please answer the following poll question: